Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multimodal Thermal Therapy With Targeted Therapy and Immunotherapy Versus Targeted Therapy and Immunotherapy Alone for Systemically Untreated Unresectable (HCC): a Prospective, Multicenter, Open-label, Randomized Controlled Trial.

NCT07596134 is registered in ClinicalTrials.gov with Zhejiang University as lead sponsor.

NCT NCT07596134
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07596134 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multimodal Thermal Therapy With Targeted Therapy and Immunotherapy Versus Targeted Therapy and Immunotherapy Alone for Systemically Untreated Unresectable (HCC): a Prospective, Multicenter, Open-label, Randomized Controlled Trial.
Lead sponsor
Zhejiang University
Phase
Not applicable
Overall status
Not yet recruiting
Start date
October 15, 2026
Completion date
October 15, 2029
Enrollment
166 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

unresectable hepatocellular carcinoma (hcc)